New GERD drug shows symptom relief in large study
NCT ID NCT05660122
First seen Nov 01, 2025 · Last updated May 22, 2026 · Updated 21 times
Summary
This study observed over 2,800 adults with erosive gastroesophageal reflux disease (GERD) who took FEXUCLUE tablets. Researchers measured how much heartburn and reflux symptoms improved after 4 to 8 weeks using patient questionnaires. The goal was to see if the drug eases discomfort in real-world use.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GASTROESOPHAGEAL REFLUX DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Samsung Medical Center
Seoul, South Korea
Conditions
Explore the condition pages connected to this study.